ML20249B573: Difference between revisions

From kanterella
Jump to navigation Jump to search
(StriderTol Bot change)
(StriderTol Bot change)
 
Line 18: Line 18:


=Text=
=Text=
{{#Wiki_filter:_ _ - - _ _ _ _ _ - _ _ _ . _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ - _ - - _ _ _ - _ -
{{#Wiki_filter:_ _ - - _ _ _ _ _ - _ _ _. _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ - _ - - _ _ _ - _ -
  ~                                                                                                                                                                     ,
~
      -                                                                                                                            UNITED STATES Distribution:
UNITED STATES h*.
  . h*.
1 NUCLEAR REGULATORY COMMISSION Distribution:
1 NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555.-0001           LJCal1an U               i                                                                                                                                 AThadani HThompson
WASHINGTON, D.C. 20555.-0001 LJCal1an U
        \ ..... p8 !                                                                                                               June 16, 1998 PNorry JBlaha CHAIRMAN                                                                                                                                     MKnapp, NMSS DFlack, NMSS KCyr, OGC G980341 The Honorable Susan M. Collins                                                                                                             EDO r/f United States Senate Washington, D.C. 20510-1904
i AThadani
\\..... p !
8 June 16, 1998 HThompson PNorry JBlaha CHAIRMAN MKnapp, NMSS DFlack, NMSS KCyr, OGC G980341 The Honorable Susan M. Collins EDO r/f United States Senate Washington, D.C. 20510-1904


==Dear Senator Collins:==
==Dear Senator Collins:==
I am responding to your {{letter dated|date=May 19, 1998|text=letter dated May 19,1998}}, regarding proposed revisions to the U.S.
I am responding to your {{letter dated|date=May 19, 1998|text=letter dated May 19,1998}}, regarding proposed revisions to the U.S.
Nuclear Regulatory Commission's (NRC) 10 CFR Part 35 regulations on medical use of byproduct material.
Nuclear Regulatory Commission's (NRC) 10 CFR Part 35 regulations on medical use of byproduct material.
Line 33: Line 34:
This proposal appears to be in keeping with the direction the Commission provided to the staff namely, to develop a risk-informed, and where appropriate, a more performance-based rule and it addressed an objection often expressed by some commenters, that NRC requirements sometimes intruded into the practice of medicine.
This proposal appears to be in keeping with the direction the Commission provided to the staff namely, to develop a risk-informed, and where appropriate, a more performance-based rule and it addressed an objection often expressed by some commenters, that NRC requirements sometimes intruded into the practice of medicine.
The Commission will carefully consider the staff proposal in light of public comments when it is received. The results of that consideration will then be available for additional public comment and discussion.
The Commission will carefully consider the staff proposal in light of public comments when it is received. The results of that consideration will then be available for additional public comment and discussion.
Sincerely,
Sincerely, Ju Shirley Ann Jackson l
                                                                                                                                                $      Ju Shirley Ann Jackson l
f Originated by':
f     Originated by': [DFlack,NMSS].
[DFlack,NMSS].
980623o319 990519 PDR       ORO     IWtCCO PDR
980623o319 990519 PDR ORO IWtCCO PDR
: w.   .      .e-rN.19.1996 11 ; lo"I'
 
              .e                                                                                                 couena
w.
    .      SUSAN M. COLLINS                                                                                 coouenrummes
.e-rN.19.1996 11 ; lo"I'
      .            we                                                                                     u,en ago NuuaN nsouncts SPt   c urrTit 173 ave sENAft04 VIL0hc
.e couena SUSAN M. COLLINS coouenrummes we u,en ago NuuaN nsouncts SPt c urrTit 173 ave sENAft04 VIL0hc
                  ==                               idnited $tates Etnatt WASHINGTON, DC 20510-1904 May 19,1998 Ms. Laura Gerke Office of Congressional Affairs Nuclear Regulatory Commission Washington, D.C. 20555 FAX 301415-8571
 
==
idnited $tates Etnatt WASHINGTON, DC 20510-1904 May 19,1998 Ms. Laura Gerke Office of Congressional Affairs Nuclear Regulatory Commission Washington, D.C. 20555 FAX 301415-8571


==Dear Ms. Gerke:==
==Dear Ms. Gerke:==
I have recently been contacted by some of my constituents who tre concerned about revisions to Part 35 of the Code of Federal Regulations relating to the medical use of radioisotopes I would appreciate it if you would provide me a summary of the changes that are being contemplated.
I have recently been contacted by some of my constituents who tre concerned about revisions to Part 35 of the Code of Federal Regulations relating to the medical use of radioisotopes I would appreciate it if you would provide me a summary of the changes that are being contemplated.
Thanks for your attention to this matter, Sincerely, i
Thanks for your attention to this matter, Sincerely, i
Susan M. Collins United States Senator i REC'D 14 SECT 19 MAY W 11: bl O m Nuoomaccreuera m
Susan M. Collins United States Senator REC'D 14 SECT i
' M8Wg}}
19 MAY W 11: bl O m Nuoomaccreuera m M8Wg
'}}

Latest revision as of 14:04, 30 November 2024

Responds to Re Proposed Revs to NRC 10CFR35 Regulations on Medical Use of Byproduct Matl.Nrc Scheduled to Provide Recommendations on Revised Part 35 to Commission in June 1998
ML20249B573
Person / Time
Issue date: 06/16/1998
From: Shirley Ann Jackson, The Chairman
NRC COMMISSION (OCM)
To: Collins S
SENATE
Shared Package
ML20249B561 List:
References
NUDOCS 9806230319
Download: ML20249B573 (1)


Text

_ _ - - _ _ _ _ _ - _ _ _. _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ - _ - - _ _ _ - _ -

~

UNITED STATES h*.

1 NUCLEAR REGULATORY COMMISSION Distribution:

WASHINGTON, D.C. 20555.-0001 LJCal1an U

i AThadani

\\..... p !

8 June 16, 1998 HThompson PNorry JBlaha CHAIRMAN MKnapp, NMSS DFlack, NMSS KCyr, OGC G980341 The Honorable Susan M. Collins EDO r/f United States Senate Washington, D.C. 20510-1904

Dear Senator Collins:

I am responding to your letter dated May 19,1998, regarding proposed revisions to the U.S.

Nuclear Regulatory Commission's (NRC) 10 CFR Part 35 regulations on medical use of byproduct material.

The NRC staff is scheduled to provide its recommendations on proposed revisions to Part 35 to the Commission in June 1998. T he proposed rule is being developed using an increased public participation process that included public workshops; meetings with various medical professional societies (including the American College of Radiology); and the posting of a "strawman" rule text on the internet for comments. The staff has carefully considered the comments received during these interactions, in preparing the proposal. After Commission approval, a proposed rule will be published in the Federal Reaister for public comment and forwarded to your office for your information. We expect to hold additional public meetings during the comment period later this year.

The issue of training and experience has received the most comments during the development of the proposed rule. Viewpoints on this issue have varied. The Commission has received comments both supporting reduction in requirements affecting personnelin the diagnostic area, including those from the American College of Cardiology and the American Society of Nuclear Cardiologists, and favoring keeping the presently existing requirements. The staff draft, while reducing the number of hours required for certain medical modalities, also specified a focus on radiation safety and proposed that personnel competency be verified through an examination.

This proposal appears to be in keeping with the direction the Commission provided to the staff namely, to develop a risk-informed, and where appropriate, a more performance-based rule and it addressed an objection often expressed by some commenters, that NRC requirements sometimes intruded into the practice of medicine.

The Commission will carefully consider the staff proposal in light of public comments when it is received. The results of that consideration will then be available for additional public comment and discussion.

Sincerely, Ju Shirley Ann Jackson l

f Originated by':

[DFlack,NMSS].

980623o319 990519 PDR ORO IWtCCO PDR

w.

.e-rN.19.1996 11 ; lo"I'

.e couena SUSAN M. COLLINS coouenrummes we u,en ago NuuaN nsouncts SPt c urrTit 173 ave sENAft04 VIL0hc

==

idnited $tates Etnatt WASHINGTON, DC 20510-1904 May 19,1998 Ms. Laura Gerke Office of Congressional Affairs Nuclear Regulatory Commission Washington, D.C. 20555 FAX 301415-8571

Dear Ms. Gerke:

I have recently been contacted by some of my constituents who tre concerned about revisions to Part 35 of the Code of Federal Regulations relating to the medical use of radioisotopes I would appreciate it if you would provide me a summary of the changes that are being contemplated.

Thanks for your attention to this matter, Sincerely, i

Susan M. Collins United States Senator REC'D 14 SECT i

19 MAY W 11: bl O m Nuoomaccreuera m M8Wg

'